Search Results - "Maeda, A I"

Refine Results
  1. 1

    Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer by Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, A I, Nojima, Yuji, Nakata, Masao

    Published in Anticancer research (01-08-2018)
    “…There is no clear evidence in the literature regarding the regulation of programmed cell death-ligand 1 (PD-L1) expression by cyclo-oxygenase-2 (COX2). In this…”
    Get full text
    Journal Article
  2. 2

    Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis by MAEDA, AI, NAKATA, MASAO, YASUDA, KOICHIRO, YUKAWA, TAKURO, SAISHO, SHINSUKE, OKITA, RIKI, HIRAMI, YUJI, SHIMIZU, KATSUHIKO

    Published in Oncology reports (01-01-2013)
    “…Vascular endothelial growth factor (VEGF) plays an important role in tumor angiogenesis. Several studies have reported that genomic VEGF polymorphisms may…”
    Get full text
    Journal Article
  3. 3

    Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer by NOJIMA, YUJI, SHIMIZU, KATSUHIKO, SAISHO, SHINSUKE, MAEDA, AI, KUROSAKI, TAKESHI, KUROSE, KOJI, OGA, TORU, OKA, MIKIO, NAKATA, MASAO

    Published in Anticancer research (01-11-2021)
    “…Background/Aim: We evaluated the efficacy of "the tumor immune microenvironment (TIME) classification" for predicting clinical response to immune checkpoint…”
    Get full text
    Journal Article
  4. 4

    Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells by OKITA, RIKI, SHIMIZU, KATSUHIKO, NOJIMA, YUJI, YUKAWA, TAKURO, MAEDA, AI, SAISHO, SHINSUKE, NAKATA, MASAO

    Published in Oncology reports (01-12-2015)
    “…EGFR/HER2 are frequently expressed in MPM tissues, however, no studies have shown the clinical benefit of using EGFR/HER2-targeting drugs in patients with…”
    Get full text
    Journal Article
  5. 5

    Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer by YUKAWA, TAKURO, SHIMIZU, KATSUHIKO, MAEDA, AI, YASUDA, KOICHIRO, SAISHO, SHINSUKE, OKITA, RIKI, NAKATA, MASAO

    Published in Oncology reports (01-01-2015)
    “…The immune microenvironment of primary tumors has been reported to be a prognostic factor. We previously reported that the tumor-infiltrating regulatory T cell…”
    Get full text
    Journal Article
  6. 6

    Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication? by Soichiro Sue, Shin Maeda

    Published in Gut and liver (30-11-2021)
    “…Vonoprazan (VPZ), a new potassium-competitive acid blocker, has been approved and used for Helicobacter pylori eradication in Japan. To date, many studies, as…”
    Get full text
    Journal Article
  7. 7

    Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication? by Soichiro Sue, Shin Maeda

    Published in Gut and liver (30-11-2021)
    “…Vonoprazan (VPZ), a new potassium-competitive acid blocker, has been approved and used for Helicobacter pylori eradication in Japan. To date, many studies, as…”
    Get full text
    Journal Article
  8. 8

    Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication? by Soichiro Sue, Shin Maeda

    Published in Gut and liver (30-11-2021)
    “…Vonoprazan (VPZ), a new potassium-competitive acid blocker, has been approved and used for Helicobacter pylori eradication in Japan. To date, many studies, as…”
    Get full text
    Journal Article
  9. 9

    Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication? by Soichiro Sue, Shin Maeda

    Published in Gut and liver (30-11-2021)
    “…Vonoprazan (VPZ), a new potassium-competitive acid blocker, has been approved and used for Helicobacter pylori eradication in Japan. To date, many studies, as…”
    Get full text
    Journal Article
  10. 10

    Novel Insights into Cr(VI)-Induced Rhamnolipid Production and Gene Expression in Pseudomonas aeruginosa RW9 for Potential Bioremediation by Fatini Mat Arisah, Norhayati Ramli, Hidayah Ariffin, Toshinari Maeda, Mohammed Abdillah Ahmad Farid, Mohd Zulkhairi Mohd Yusoff

    Published in Journal of microbiology and biotechnology (30-09-2024)
    “…Rhamnolipid (RL) is renowned for its efficacy in bioremediating several types of organic and metal contaminants. Nevertheless, there has been a scarcity of…”
    Get full text
    Journal Article
  11. 11

    Reducing Carbohydrate from Individual Sources Has Differential Effects on Glycosylated Hemoglobin in Type 2 Diabetes Mellitus Patients on Moderate Low- Carbohydrate Diets by Hajime Haimoto, Shiho Watanabe, Keiko Maeda, Takashi Murase, Kenji Wakai

    Published in Diabetes & metabolism journal (30-05-2021)
    “…Background: We evaluated decreases in glycosylated hemoglobin (HbA1c) achieved by reducing carbohydrate from various sources in type 2 diabetes mellitus…”
    Get full text
    Journal Article
  12. 12

    Keratinocyte-Like Cells Trans-Differentiated from Human Adipose-Derived Stem Cells, Facilitate Skin Wound Healing in Mice by Jonghun Kim, Toshio Hasegawa, Akino Wada, Yuichiro Maeda, Shigaku Ikeda

    Published in Annals of dermatology (05-08-2021)
    “…Background: Mesenchymal stem cells (MSCs) have been reported to promote wound healing in both animal models and human studies. Among MSCs, adipose-derived stem…”
    Get full text
    Journal Article
  13. 13

    Frailty, Sarcopenia, Cachexia, and Malnutrition in Heart Failure by Daichi Maeda, Yudai Fujimoto, Taisuke Nakade, Takuro Abe, Shiro Ishihara, Kentaro Jujo, Yuya Matsue

    Published in Korean circulation journal (2024)
    “…With global aging, the number of patients with heart failure has increased markedly. Heart failure is a complex condition intricately associated with aging,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Medial soft tissue release is also related to the anterior stability of cruciate-retaining total knee arthroplasty: a cadaveric study by Sayako Sakai, Shinichiro Nakamura, Takahiro Maeda, Shinichi Kuriyama, Kohei Nishitani, Yugo Morita, Yusuke Yamawaki, Yuki Shinya, Shuichi Matsuda

    Published in Knee surgery & related research (01-01-2024)
    “…Background Medial soft tissue release is occasionally performed to achieve mediolateral ligament balance in total knee arthroplasty (TKA), whose sequential…”
    Get full text
    Journal Article
  16. 16

    Impact of sarcopenia on biliary drainage during neoadjuvant therapy for pancreatic cancer by Kunio Kataoka, Eizaburo Ohno, Takuya Ishikawa, Kentaro Yamao, Yasuyuki Mizutani, Tadashi Iida, Hideki Takami, Osamu Maeda, Junpei Yamaguchi, Yukihiro Yokoyama, Tomoki Ebata, Yasuhiro Kodera, Hiroki Kawashima

    Published in Clinical endoscopy (30-01-2024)
    “…Background/Aims: Since the usefulness of neoadjuvant chemo(radiation) therapy (NAT) for pancreatic cancer has been demonstrated, recurrent biliary obstruction…”
    Get full text
    Journal Article
  17. 17

    Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study by Vy H. Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen

    Published in Clinical and molecular hepatology (01-10-2023)
    “…Background/Aims: Understanding of nonalcoholic fatty liver disease (NAFLD) continues to expand, but the relationship between race and ethnicity and NAFLD…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Migration of a Percutaneous Endoscopic Gastrojejunostomy Tube into the Colon with Small Intestinal Telescoping by Shinya Taki, Takao Maekita, Mayumi Sakata, Kazuhiro Fukatsu, Yoshimasa Maeda, Mikitaka Iguchi, Hidefumi Ito, Masayuki Kitano

    Published in Clinical endoscopy (30-11-2019)
    “…Continuous duodenal levodopa/carbidopa intestinal gel delivery by a gastrostomy infusion system improves control of Parkinson’s disease. The overall…”
    Get full text
    Journal Article
  20. 20

    Risk Factors of Neuropathic Pain after Total Hip Arthroplasty by Kazumasa Maeda, Motoki Sonohata, Masaru Kitajima, Shunsuke Kawano, Masaaki Mawatari

    Published in Hip & pelvis (31-12-2018)
    “…Purpose: Pain caused by osteoarthritis is primarily nociceptive pain; however, it is considered that a component of this pain is due to neuropathic pain (NP)…”
    Get full text
    Journal Article